These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33414788)

  • 1. A Novel Gene Delivery Vector of Agonistic Anti-Radioprotective 105 Expressed on Cell Membranes Shows Adjuvant Effect for DNA Immunization Against Influenza.
    Yamazaki T; Biswas M; Kosugi K; Nagashima M; Inui M; Tomono S; Takagi H; Ichimonji I; Nagaoka F; Ainai A; Hasegawa H; Chiba J; Akashi-Takamura S
    Front Immunol; 2020; 11():606518. PubMed ID: 33414788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.
    Nagai Y; Shimazu R; Ogata H; Akashi S; Sudo K; Yamasaki H; Hayashi S; Iwakura Y; Kimoto M; Miyake K
    Blood; 2002 Mar; 99(5):1699-705. PubMed ID: 11861286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids.
    Yamazaki T; Nagashima M; Ninomiya D; Arai Y; Teshima Y; Fujimoto A; Ainai A; Hasegawa H; Chiba J
    Jpn J Infect Dis; 2011; 64(1):40-9. PubMed ID: 21266754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
    Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
    Operschall E; Pavlovic J; Nawrath M; Mölling K
    Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
    Divanovic S; Trompette A; Atabani SF; Madan R; Golenbock DT; Visintin A; Finberg RW; Tarakhovsky A; Vogel SN; Belkaid Y; Kurt-Jones EA; Karp CL
    J Endotoxin Res; 2005; 11(6):363-8. PubMed ID: 16303092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
    Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge.
    Vecino WH; Quanquin NM; Martinez-Sobrido L; Fernandez-Sesma A; García-Sastre A; Jacobs WR; Fennelly GJ
    Virology; 2004 Aug; 325(2):192-9. PubMed ID: 15246259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes.
    Kerekov NS; Ivanova II; Mihaylova NM; Nikolova M; Prechl J; Tchorbanov AI
    Immunol Res; 2014 Oct; 60(1):23-34. PubMed ID: 24515613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
    Moon HJ; Lee JS; Talactac MR; Chowdhury MY; Kim JH; Park ME; Choi YK; Sung MH; Kim CJ
    Vet Microbiol; 2012 Dec; 160(3-4):277-89. PubMed ID: 22763171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
    Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM
    J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The radioprotective 105/MD-1 complex links TLR2 and TLR4/MD-2 in antibody response to microbial membranes.
    Nagai Y; Kobayashi T; Motoi Y; Ishiguro K; Akashi S; Saitoh S; Kusumoto Y; Kaisho T; Akira S; Matsumoto M; Takatsu K; Miyake K
    J Immunol; 2005 Jun; 174(11):7043-9. PubMed ID: 15905547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant influenza A virus hemagglutinin HA2 subunit protects mice against influenza A(H7N9) virus infection.
    To KK; Zhang AJ; Chan AS; Li C; Cai JP; Lau CC; Li CG; Jahan AS; Wu WL; Li L; Tsang AK; Chan KH; Chen H; Yuen KY
    Arch Virol; 2015 Mar; 160(3):777-86. PubMed ID: 25616843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.